In an announcement made on Thursday, tech giant Apple said that it is issuing a major recall of AC wall plug adapters bundled with its MacBook laptops and iPads between 2003 and 2015, in select countries. The under-recall adapters were also included in the Apple World Travel Adapter Kit.
According to the Apple announcement, the countries in which the company is recalling AC wall plug adapters sold with MacBook laptops and iPads include continental Europe, Brazil, Argentina, Australia, New Zealand, and South Korea.
About the reason prompting the recall of AC wall plug adapters packaged with select MacBooks and iPads, Apple said that a design flaw in the adapters - which were shipped outside the US in the last 12 years - can cause the pin to break off in sockets; thereby posing a potential risk of electrical shock if a broken AC plug is touched.
Apple has revealed that the defect in the AC wall plug adapters has reportedly been the reason for electrical shock to users in at least 12 incidents.
In announcing the recall of AC wall plug adapters, Apple said that it will voluntarily give the users of the recall-affected AC wall plug adapters a new, redesigned model 'free of cost.'
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).